FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize| U.S. Food and Drug Administration
Reporting on prescription/OTC medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug.| U.S. Food and Drug Administration
Learn more about online pharmacy safety.| U.S. Food and Drug Administration
Creating a medication tailored to the needs of an individual patient. FDA answers the “what” and “why” of compounding.| U.S. Food and Drug Administration
Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products. Reporting can be done through our online reporting portal or by downloading, completing and then submitting FDA Form 3500 (Health Professional) or 3500B (Consumer/Patient) to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.| www.accessdata.fda.gov